<DOC>
	<DOCNO>NCT02534480</DOCNO>
	<brief_summary>NGP 555 small molecule preventative therapy aim reduce Alzheimer 's disease amyloid buildup target Abeta 42 production .</brief_summary>
	<brief_title>Neurogenetic Pharmaceuticals ( NGP ) 555 Healthy Young Volunteers ( Single-ascending Dose )</brief_title>
	<detailed_description>NGP 555 gamma-secretase modulator selective mechanism reduce Abeta 42 raise short Abeta form Abeta 37 38 . NGP 555 developed preventative disease modify therapy Alzheimer 's disease .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1 . Male female volunteer age 1855 yrs good health determine medical history , physical examination , clinical laboratory study , electrocardiogram ( ECGs ) , vital sign , investigator judgment 2 . Volunteer voluntarily agree participate study sign Institutional Review Board ( IRB ) approve informed consent prior perform screen procedure 3 . Female volunteer childbearing potential must agree use medically acceptable method contraception ( e.g. , abstinence , intrauterine device . 4 . Male healthy volunteer willing use barrier contraception . 5 . Body mass index ( BMI ) ≥ 18.0 kg/m2 ≤ 32.0 kg/m2 1 . History seizure disorder , symptomatic seizure ( include history simple febrile seizure childhood ) past present medical condition , opinion investigator potential reduce seizure threshold ( e.g. , history head trauma concussion , previous alcohol abuse , substance abuse ) 2 . Any concurrent disease condition , opinion Investigator , would make volunteer unsuitable participation clinical study 3 . History alcohol and/or illicit drug abuse within two year entry 4 . Any psychiatric diagnosis symptom ( e.g. , hallucination , major depression , anxiety delusion ) 5 . History cerebrovascular event nonvasovagal related loss consciousness 6 . History cardiac arrhythmia , ischemic heart disease cerebrovascular disease 7 . Hepatic impairment define &gt; 1.3 time upper limit normal range serum liver enzymes 8 . Renal impairment define abnormal range serum creatinine . 9 . Presence clinically significant orthostatic hypotension ( fall systolic blood pressure &gt; 20 mmHg fall diastolic blood pressure &gt; 10 mmHg ; increase heart rate &gt; 20 beat per minute [ bpm ] ) 10 . Corrected QT interval ( QTc ) value &gt; 450 m male &gt; 470 m female . 11 . Volunteers abnormally low serum B12 , folate abnormal thyroid function test 12 . Positive Screening test Hepatitis B surface antigen ( HBsAg ) , Hepatitis C antibody , human immunodeficiency virus ( HIV ) antibody 13 . Positive urine test alcohol drug 14 . Suicidal ideation 15 . Female volunteer breastfeed female volunteer positive urine pregnancy test 16 . Clinically significant deviation normal physical examination , vital sign clinical laboratory test 17 . Volunteer unable understand protocol requirement , instruction studyrelated restriction , nature , scope possible consequence clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Amyloid</keyword>
</DOC>